WO2012096307A1 - 新規糖転移酵素遺伝子及びその使用 - Google Patents
新規糖転移酵素遺伝子及びその使用 Download PDFInfo
- Publication number
- WO2012096307A1 WO2012096307A1 PCT/JP2012/050379 JP2012050379W WO2012096307A1 WO 2012096307 A1 WO2012096307 A1 WO 2012096307A1 JP 2012050379 W JP2012050379 W JP 2012050379W WO 2012096307 A1 WO2012096307 A1 WO 2012096307A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- flavone
- polynucleotide
- protein
- sugar
- activity
- Prior art date
Links
- 0 OCC([C@](C(C1O)O)O)O[C@]1Oc(cc1O)cc(OC(c(cc2)ccc2OC([C@](C2O)O)O*(COC(CC(O)=O)=O)C2O)=C2)c1C2=O Chemical compound OCC([C@](C(C1O)O)O)O[C@]1Oc(cc1O)cc(OC(c(cc2)ccc2OC([C@](C2O)O)O*(COC(CC(O)=O)=O)C2O)=C2)c1C2=O 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/46—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/605—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin to a 1-benzopyran-2-on (or the chalcones and hydrogenated chalcones thereof, e.g. coumermycin, novobiocin, novenamin)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Definitions
- the present invention relates to a polynucleotide encoding a protein having an activity of transferring a sugar to both the 4'-position and 7-position hydroxyl groups of flavone, and use thereof.
- the flower color is attributed to four types of pigments: flavonoids, carotenoids, chlorophyll, and betalain.
- flavonoids exhibit various colors such as yellow, red, purple, and blue.
- Anthocyanin One group exhibiting red, purple, and blue is collectively called anthocyanin, and the variety of anthocyanin structure is one of the causes of the variety of flower colors.
- Anthocyanins can be roughly classified into three groups depending on the structure of aglycone, considering their biosynthetic pathway. Vivid red flowers such as carnation and geranium often contain pelargonidin-type anthocyanins, and blue and purple flowers often contain delphinidin-type anthocyanins. The lack of blue and purple varieties in roses, carnations, chrysanthemums and lilies is due to the inability of these plants to synthesize delphinidin-type anthocyanins.
- anthocyanins are modified with one or more aromatic acyl groups, (ii) anthocyanins coexist with pigments such as flavones and flavonols (Iii) iron ions and aluminum ions coexist with anthocyanins, (iv) the pH of vacuoles where anthocyanins are localized increases from neutral to weakly alkaline, or (v) anthocyanins, pigments, metals It is considered that one of ions forming a complex (such anthocyanins are called metalloanthocyanins) is necessary (hereinafter, Non-Patent Document 1).
- Flavonoid and anthocyanin biosynthesis has been well studied, and related biosynthetic enzymes and genes encoding them have been identified (see Non-Patent Document 2 and FIG. 1 below).
- the gene of flavonoid 3 ', 5'-hydroxylase (F3'5'H) that hydroxylates the flavonoid B ring necessary for delphinidin biosynthesis has been obtained from many plants.
- these F3′5′H genes are introduced into carnations (hereinafter, see Patent Document 1), roses (hereinafter, Non-Patent Document 3, Patent Documents 2, 3), and chrysanthemums (hereinafter, Patent Document 4).
- a genetically modified plant in which delphinidin is accumulated in the petals and the color of the flower changes to blue has been created (see Non-Patent Document 4 below).
- Such carnations and roses are commercially available.
- a flavone is a kind of organic compound and is a cyclic ketone of a flavan derivative.
- flavones derivatives belonging to flavones are referred to as “flavones”.
- Flavonoids (flavones) in a broad sense are one of the flavonoid categories. Among flavonoids, those having a flavone structure as a basic skeleton and having no hydroxyl group at the 3-position are classified as “flavones”.
- flavones include apigenin (apigenin; 4 ′, 5,7-trihydroxyflavone) and luteolin (luteolin; 3 ′, 4 ′, 5,7-tetrahydroxyflavone).
- flavone means a flavone in a broad sense, that is, a derivative belonging to flavones.
- the gene of flavone synthase (FNS) necessary for flavone biosynthesis is also obtained from many plants. It has been known that flavones have an effect of darkening the color of anthocyanins in blue when they coexist with anthocyanins, and these FNS genes have attracted attention in flower color modification.
- FNS gene together with F3′5′H into a rose that does not have the ability to synthesize flavones, delphinidin is accumulated in petals, and at the same time, flavones are accumulated, and the color of the flower is further changed to blue (hereinafter referred to as a patent). Reference 5).
- flavone In addition to flower-blue coloration, flavone absorbs ultraviolet rays, so it protects plants from ultraviolet rays and functions as a signal for insect vision in insect flowers. Flavones are also involved in the interaction between plants and soil microorganisms. Furthermore, flavones are also used as a material for food and cosmetics as a healthy component. For example, flavone is said to have an anti-cancer effect, and it has been demonstrated that ingestion of foods containing a large amount of flavone can help treat or prevent cancer.
- genes that modify anthocyanins and flavones have been obtained from many plants.
- glycosyltransferases acyltransferases, methyltransferases, and the like.
- glycosyltransferase (GT) that catalyzes glycosylation is described.
- GT glycosyltransferase
- a gene encoding a protein having an activity of transferring glucose to the hydroxyl group at the 3-position of anthocyanin has been isolated from gentian, perilla, petunia, rose, snapdragon (hereinafter, non-patent documents 4 to 6, patents). Reference 6).
- a gene encoding a protein having an activity of transferring glucose to the hydroxyl group at the 5-position of anthocyanin has been isolated from perilla, petunia, gentian, verbena, torenia and the like (hereinafter, non-patent documents 5 to 7, patent document 7). reference).
- a gene encoding a protein having an activity of transferring glucose to the 7-position hydroxyl group of flavone has been isolated from Arabidopsis thaliana (refer to Non-Patent Document 8 below).
- a gene encoding a protein having the activity of transferring glucose to the 7-position hydroxyl group of baicalen has been isolated from Scutella niger, and the protein expressing this gene in Escherichia coli has the activity of transferring glucose to the 7-position hydroxyl group of flavonoids. It has also been reported to catalyze a reaction showing the following (see Non-Patent Document 9).
- a gene encoding a protein having an activity of transferring glucose to the hydroxyl group at the 3'-position of anthocyanin has been isolated from gentian, sturgeon, and cineraria (see Patent Document 8 below).
- glycosyltransferase uses UDP-glucose as a sugar donor, but recently a glycosyltransferase using acylglucose as a sugar donor has also been identified.
- a gene encoding a protein having an activity of transferring glucose to the hydroxyl group at the 5-position of anthocyanin-3 glucoside was isolated from carnation, and a gene encoding a protein having an activity of transferring glucose to the hydroxyl group at the 7-position was isolated from delphinium. (Refer to Non-Patent Document 10 below).
- glycosyltransferases have proteins having an activity of transferring glucose to various hydroxyl groups.
- many glycosyltransferases whose functions have not been identified still remain.
- a gene encoding a protein having an activity of transferring a sugar to the 4 ′ position of a flavonoid, or a gene encoding a protein having an activity of transferring a sugar sequentially to two hydroxyl groups of the A ring and B ring of the flavonoid Has not yet been identified. It has been reported that a protein in which a glycosyltransferase gene derived from Livingstone Daisy is expressed in E.
- metalloanthocyanins typified by the pigments of camellia, cornflower, salvia, and nemophila are composed of 6 anthocyanins, 6 flavones, and 2 atoms of metal ions, and each component aggregates to form a stable blue pigment.
- nemophila metalloanthocyanin is formed from nemophilin (see FIG. 3), malonyl apigenin 4 ′, 7-diglucoside (see FIG. 4), Mg 2+ , and Fe 3+ .
- Salvia metalloanthocyanins are formed from cyanosalvianin (see FIG.
- the blue Dutch Iris petal contains a flavone with sugar added at the 4 'position.
- the addition of two sugars to the flavone increases the solubility and changes the physical properties, so that it can be expected to expand its use as a health food, pharmaceutical and cosmetic material.
- the problem to be solved by the present invention is to provide a polynucleotide encoding a protein having an activity of transferring sugar to both the 4′-position and 7-position hydroxyl groups of flavone and use thereof. .
- the present applicants have intensively studied and repeated experiments. As a result, a single polynucleotide encoding a protein having an activity of transferring a sugar to both the 4′-position and the 7-position hydroxyl groups of flavone is obtained. It was released and it was confirmed that it could be used, and the present invention was completed. That is, the present invention is as follows.
- [11] A method for adding a sugar to both the 4′-position and the 7-position hydroxyl groups of a flavone using the polynucleotide according to any one of [1] to [7].
- a protein having an activity to transfer sugar specifically to both the 4'-position and 7-position hydroxyl groups of flavone is used for modification of flower color by expressing constitutively or tissue-specifically in a plant.
- Can do is used for producing a flavone in which sugars are added to the hydroxyl groups at both the 4'-position and the 7-position, and foods, pharmaceuticals, cosmetics and the like obtained by the production method.
- FIG. 5 is an alignment diagram comparing the amino acid sequences of NmGT3 and NmGT4 (identity 31%, nucleic acid level identity 51%).
- FIG. 4 is an alignment diagram comparing the amino acid sequences of enzymes that add sugars to the 2'-position of NmGT3 and carnation chalcononaringenin (identity 32%, nucleic acid level identity 47%).
- FIG. 2 is a high-performance liquid chromatogram of a solution obtained by enzymatic reaction of a SuGT5 protein solution and apigenin 7-glucoside.
- FIG. 4 is an alignment diagram comparing the amino acid sequences of SuGT5 and NmGT3 (identity 38%, nucleic acid level identity 47%).
- FIG. 5 is an alignment diagram comparing the amino acid sequences of SuGT5 and NmGT4 (identity 51%, nucleic acid level identity 58%).
- the present invention provides the following (a) to (e): (A) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1 or 3 or 12; (B) a polynucleotide that hybridizes under stringent conditions with a polynucleotide comprising a nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO: 1 or 3 or 12, and has hydroxyl groups at both the 4′-position and the 7-position of flavone
- a polynucleotide encoding a protein having an activity to transfer sugar to (C) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2, 4 or 13; (D) the amino acid sequence of SEQ ID NO: 2 or 4 or 13, consisting of an amino acid sequence in which one or several amino acids are deleted, substituted, inserted and / or added, and the 4 ′ and 7th positions of flavone
- the term “polynucleotide” means DNA or RNA.
- stringent conditions refers to conditions that enable selective and detectable specific binding between a polynucleotide or an oligonucleotide and genomic DNA. Stringent conditions are defined by a suitable combination of salt concentration, organic solvent (eg, formamide), temperature, and other known conditions. That is, stringency increases depending on whether the salt concentration is decreased, the organic solvent concentration is increased, or the hybridization temperature is increased. In addition, washing conditions after hybridization also affect stringency. This wash condition is also defined by salt concentration and temperature, and the stringency of the wash increases with decreasing salt concentration and increasing temperature.
- the term “stringent conditions” means that the degree of “identity” or “homology” between the base sequences is, for example, about 80% or more, preferably about 90% or more, more preferably, on the average on the whole. It means a condition that specifically hybridizes only between nucleotide sequences having high homology, such as about 95% or more, more preferably 97% or more, and most preferably 98% or more.
- Examples of the “stringent conditions” include conditions in which the sodium concentration is 150 to 900 mM, preferably 600 to 900 mM, pH 6 to 8 at a temperature of 60 ° C. to 68 ° C.
- Hybridization was performed under the conditions of 5 x SSC (750 mM NaCl, 75 mM trisodium citrate), 1% SDS, 5 x Denhardt's solution 50% formaldehyde, and 42 ° C.
- 5 x SSC 750 mM NaCl, 75 mM trisodium citrate
- 1% SDS 1% SDS
- 5 x Denhardt's solution 50% formaldehyde and 42 ° C.
- 0.1 x SSC 15 mM NaCl, 1.5 mM Acid trisodium
- 0.1% SDS washed at 55 ° C.
- Hybridization may be performed by a method known in the art, such as the method described in Current Protocols in Molecular Biology (edited by Frederick M, Ausubel et al, 1987), or the like. It can carry out according to the method according to it. Moreover, when using a commercially available library, it can carry out according to the method as described in an attached instruction manual.
- the gene selected by such hybridization may be naturally derived, for example, a plant-derived gene or a non-plant-derived gene.
- the gene selected by hybridization may be cDNA, genomic DNA, or chemically synthesized DNA.
- amino acid sequence in which one or several amino acids are deleted, substituted, inserted and / or added is, for example, 1 to 20, preferably 1 to 5, more preferably 1 to 3 Means an amino acid sequence wherein a certain number of amino acids are deleted, substituted, inserted and / or added.
- Site-directed mutagenesis which is one of genetic engineering techniques, is useful because it can introduce a specific mutation at a specific position. Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory It can be performed according to the method described in Press, Cold Spring Harbor, NY, 1989, etc.
- the DNA according to the present invention is a primer designed based on the nucleotide sequence of the target gene using a method known to those skilled in the art, for example, a method of chemically synthesizing by the phosphoramidide method, a plant nucleic acid sample as a template It can be obtained by a nucleic acid amplification method using
- the terms “identity” and “homology” constitute a chain between two chains in a polypeptide sequence (or amino acid sequence) or polynucleotide sequence (or base sequence). Means the amount (number) of each amino acid residue or bases that can be determined to be identical in each other's fitness, and the sequence correlation between two polypeptide sequences or two polynucleotide sequences It means a degree, and “identity” and “homology” can be easily calculated. Many methods are known for measuring homology between two polynucleotide or polypeptide sequences, and the terms ⁇ identity '' and ⁇ homology '' are well known to those skilled in the art (see, for example, Lesk, A. M.
- the numerical values of “identity” and “homology” described in the present specification may be numerical values calculated using a homology search program known to those skilled in the art, unless otherwise specified. Preferably, the value is calculated using the ClustalW program of the MacVector application (version 9.5, Oxford Molecular Ltd., Oxford, England).
- the polynucleotide (nucleic acid, gene) of the present invention “encodes” a protein of interest.
- encode means that the protein of interest is expressed in a state having the activity.
- encode includes both the meaning of encoding the protein of interest as a continuous structural sequence (exon) or encoding via an intervening sequence (intron).
- a gene having a native base sequence can be obtained, for example, by analysis using a DNA sequencer as described in the following examples.
- DNA encoding an enzyme having a modified amino acid sequence can be synthesized using conventional site-directed mutagenesis or PCR based on DNA having a native base sequence.
- a DNA fragment to be modified is obtained by restriction enzyme treatment of native cDNA or genomic DNA, using this as a template, site-directed mutagenesis or PCR method is performed using a primer into which a desired mutation is introduced, A modified DNA fragment is obtained. Thereafter, the DNA fragment into which this mutation has been introduced may be ligated with a DNA fragment encoding another part of the target enzyme.
- a DNA encoding an enzyme consisting of a shortened amino acid sequence for example, an amino acid sequence longer than the target amino acid sequence
- a DNA encoding a full-length amino acid sequence is cleaved with a desired restriction enzyme, and the result When the obtained DNA fragment does not encode the entire target amino acid sequence, a DNA fragment consisting of the missing portion sequence may be synthesized and ligated.
- the obtained polynucleotide is expressed using a gene expression system in Escherichia coli and yeast, and the enzyme activity is measured, so that the obtained polynucleotide has sugars at both the 4′-position and 7-position hydroxyl groups of the flavone. It can be confirmed that it encodes a protein having an activity of transferring. Furthermore, by expressing the polynucleotide, a protein having an activity of transferring a sugar to both the 4′-position and 7-position hydroxyl groups of the flavone, which is a polynucleotide product, can be obtained.
- a protein having an activity of transferring a sugar to both the 4′-position and the 7-position hydroxyl group of flavone can be obtained using an antibody against the polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 2 or 4 or 13.
- a polynucleotide encoding a protein having an activity of transferring a sugar to both the 4′-position and 7-position hydroxyl groups of flavones derived from other organisms can be cloned.
- the present invention also relates to (recombinant) vectors, in particular expression vectors, comprising a polynucleotide as described above, and also to a host transformed with the vector.
- Prokaryotes or eukaryotes can be used as the host.
- a common host such as a bacterium, for example, a bacterium belonging to the genus Escherichia, for example, an Escherichia coli, a microorganism belonging to the genus Bacillus, for example, Bacillus subtilis can be used.
- eukaryotes lower eukaryotes such as eukaryotic microorganisms such as yeast or filamentous fungi that are fungi can be used.
- yeast examples include microorganisms belonging to the genus Saccharomyces, such as Saccharomyces cerevisiae.
- filamentous fungi examples include microorganisms belonging to the genus Aspergillus, such as Aspergillus oryzae. Examples include microorganisms belonging to the genus Aspergillus niger and Penicillium.
- animal cells or plant cells can be used.
- animal cells cell systems such as mice, hamsters, monkeys, and humans are used.
- insect cells such as silkworm cells and silkworm adults themselves are used. Used as a host.
- the expression vector of the present invention contains an expression control region, for example, a promoter, a terminator, an origin of replication, etc., depending on the type of host into which they are introduced.
- an expression control region for example, a promoter, a terminator, an origin of replication, etc., depending on the type of host into which they are introduced.
- promoters for bacterial expression vectors conventional promoters such as trc promoter, tac promoter, lac promoter, etc. are used, and as yeast promoters, for example, glyceraldehyde 3-phosphate dehydrogenase promoter, PH05 promoter, etc. are used.
- yeast promoters for example, glyceraldehyde 3-phosphate dehydrogenase promoter, PH05 promoter, etc.
- the promoter for filamentous fungi for example, amylase promoter, trpC promoter and the like are used.
- viral promoters such as SV40 early promoter and SV40 rate promoter are used.
- promoters that constitutively express polynucleotides in plant cells include cauliflower mosaic virus 35S RNA promoter, rd29A gene promoter, rbcS promoter, mac-1 promoter, and the like.
- tissue-specific gene expression a promoter of a gene that is specifically expressed in the tissue can be used.
- An expression vector can be prepared according to a conventional method using a restriction enzyme, ligase or the like.
- transformation of a host with an expression vector can be performed according to a conventional method.
- the host transformed with the expression vector is cultured, cultivated or grown, and recovered from the culture or medium according to a conventional method, for example, filtration, centrifugation, cell disruption, gel filtration chromatography, ion exchange chromatography, etc.
- the target protein can be obtained by purification.
- a gene encoding a protein having an activity of transferring a sugar to both the 4′-position and the 7-position hydroxyl group of nemophila or salvia-derived flavone is described.
- the polynucleotide according to the present invention includes nemophila.
- the gene is not limited to a gene derived from salvia, and the origin of a gene encoding a protein having an activity of transferring sugars to both the 4′-position and the 7-position hydroxyl group of flavone is a microorganism such as a plant, an animal, As long as it has an activity to transfer sugars to both the 4′-position and the 7-position hydroxyl group of flavone, it can be used to change the flower color in plants regardless of origin.
- the present invention can be obtained by introducing an exogenous polynucleotide encoding a protein having an activity of transferring a sugar to both the 4′-position and the 7-position hydroxyl group of a flavone into a plant and incorporating the same into the plant. Also related to plants or their progeny or parts or tissues thereof. The form of the part or tissue can be a cut flower.
- a polynucleotide encoding a protein having an activity of transferring sugar to both the 4′-position and the 7-position hydroxyl group of the flavone according to the present invention, both the 4′-position and the 7-position of flavone can be glycosylated. Alternatively, glycosylation of both the 4′-position and the 7-position of the flavone can be suppressed, and as a result, the flower color in the plant can be changed.
- a technique for introducing a polynucleotide into a plant and expressing the polynucleotide constitutively or tissue-specifically can be used.
- Introduction of DNA into a plant can be performed by methods known to those skilled in the art, such as the Agrobacterium method, binary vector method, electroporation method, PEG method, particle gun method, and the like.
- transformable plants include roses, carnations, chrysanthemum, snapdragons, cyclamen, orchids, turkeys, freesia, gerbera, gladiolus, gypsophila, kalanchoe, lily, pelargonium, geranium, petunia, torenia, tulip, anthurium, moth orchid , Rice, barley, wheat, rapeseed, potato, tomato, poplar, banana, eucalyptus, sweet potato, soybean, alfalsa, rubin, corn, cauliflower, dahlia and the like.
- the present invention also relates to a processed product (cut flower processed product) using the cut flower.
- the cut flower processed product includes, but is not limited to, a pressed flower using the cut flower, a preserved flower, a dried flower, a resin sealed product, and the like.
- the flavone produced by the production method of the present invention and having a sugar added to both the 4'-position and the 7-position hydroxyl group can be used for applications such as food, pharmaceutical and cosmetic production methods.
- RNAi method it is also possible to suppress the expression of a target gene in a plant by an antisense method, a cosuppression method, an RNAi method, or the like.
- Methods for suppressing the expression of the gene of interest can be performed according to methods known to those skilled in the art. For example, antisense RNA / DNA technology [Biotechnology, 9, 358 (1992), Trends in Biotechnology, 10,1087 ( 1992), Trends in Biotechnology, 10, 152 (1992)], triple helix technology [Trends in Biotechnology, 10, 132 (1992)] and the like.
- suppression of gene expression is performed using a single-stranded nucleic acid molecule comprising all or part of the same nucleotide sequence as the antisense strand of the gene according to the present invention.
- a method is known as an antisense method.
- expression of a target gene is suppressed by expressing RNA having a sequence complementary to the gene whose expression is to be suppressed at a high level.
- single-stranded RNA comprising the entire nucleotide sequence identical to the antisense strand of the polynucleotide (gene) according to the present invention can be used.
- a single-stranded RNA comprising a part of the same nucleotide sequence as the antisense strand of the gene according to the present invention can also be used.
- Such partial single-stranded RNA is not particularly limited as long as it can suppress the expression of the gene according to the present invention and can be appropriately designed by those skilled in the art, but is preferably specific for the gene according to the present invention.
- the chain length is preferably 5 to 100 nucleotides, more preferably 5 to 50 nucleotides, and even more preferably 10 to 20 nucleotides.
- Suppression of gene expression is performed using a single-stranded nucleic acid molecule comprising all or part of the same nucleotide sequence as the sense strand of the gene according to the present invention. That is, this sense single-stranded nucleic acid can be used for the suppression of gene expression according to the present invention, similarly to the above-described antisense single-stranded nucleic acid.
- single-stranded RNA comprising the entire nucleotide sequence identical to the sense strand of the gene according to the present invention can be used.
- a single-stranded RNA comprising a part of the same nucleotide sequence as the gene sense strand can also be used.
- Such partial single-stranded RNA is not particularly limited as long as it can suppress the expression of the gene according to the present invention and can be appropriately designed by those skilled in the art, but is preferably specific for the gene according to the present invention.
- the chain length is preferably 5 to 100 nucleotides, more preferably 5 to 50 nucleotides, and even more preferably 10 to 20 nucleotides.
- suppression of gene expression is performed using a double-stranded nucleic acid molecule comprising all or part of the same nucleotide sequence as the gene according to the present invention.
- a double-stranded nucleic acid molecule comprising all or part of the same nucleotide sequence as the gene according to the present invention.
- an antisense or sense single-stranded nucleic acid of the gene according to the present invention can be expressed in angiosperms.
- the double-stranded nucleic acid molecule according to the present invention is preferably DNA, and its chain length and specific nucleotide sequence correspond to the chain length and nucleotide sequence of the intended single-stranded nucleic acid molecule.
- the double-stranded nucleic acid molecule according to the present invention when the antisense single-stranded nucleic acid is expressed, includes the antisense strand of the gene according to the present invention as a coding strand.
- the double-stranded nucleic acid molecule according to the present invention when the sense single-stranded nucleic acid is expressed, includes the sense strand of the gene according to the present invention as a coding strand.
- Double-stranded nucleic acid molecules can be expressed in plants using methods known to those skilled in the art.
- an expression vector containing a promoter, a double-stranded nucleic acid molecule according to the present invention, a transcription terminator, etc. is introduced into a target plant, and the resulting plant is cultivated to express the double-stranded nucleic acid molecule.
- An expression vector can be introduced into a plant by methods known to those skilled in the art, for example, the Agrobacterium method, binary vector method, electroporation method, PEG method, particle gun method and the like.
- RNA As another example of the method for suppressing gene expression using the nucleic acid molecule according to the present invention, there is a cosuppression method.
- a sense double-stranded DNA having the entire nucleotide sequence of the gene according to the invention is introduced into the target plant.
- the sense single-stranded RNA according to the present invention is expressed, and the expression of the gene is extremely suppressed by this RNA (Plant Cell 9: 1357-1368, 1997).
- the obtained protein solution was centrifuged (10000 rpm, 4 ° C., 10 minutes), and ammonium sulfate was added to the collected supernatant to a saturation concentration of 30%. After stirring at 4 ° C. for 1 hour, the supernatant was collected by centrifugation (10000 rpm, 4 ° C., 10 minutes). Ammonium sulfate was added to the resulting supernatant to a saturation concentration of 70%, stirred at 4 ° C. for 1 hour, and then centrifuged (10000 rpm, 4 ° C., 10 minutes) to obtain a precipitate.
- Example 2 Determination of retention time / absorption maximum of apigenin 4′-glucoside
- apigenin 4′-glucoside In order to clarify the biosynthetic pathway of flavone 4 ′, 7-diglucoside, it was decided to determine the retention time and absorption maximum of apigenin 4′-glucoside.
- apigenin 4′-glucoside and apigenin 7-glucoside should be biosynthesized as intermediate products (see FIG. 8).
- FIG. 8 the analysis result of Example 1, it was expected that peaks other than apigenin 7-glucoside and apigenin 4 ′, 7-diglucoside, which had a sample, appeared.
- apigenin 4′-glucoside As a result, a flavone having a retention time close to that of apigenin 7-glucoside was biosynthesized, and this was determined to be apigenin 4′-glucoside (see FIG. 7). The retention time and absorption maximum of apigenin 4′-glucoside could be determined.
- Example 3 Acquisition of a candidate gene for a gene encoding a protein having an activity of transferring a sugar to the 4′-position and the 7-position hydroxyl group of flavone] ⁇ Isolation of total RNA> Total RNA was isolated from petals of Nemophila stage 1 and 2 using Plant RNAeasy Kit (QIAGEN) according to the protocol recommended by the manufacturer. ⁇ Expression analysis of cDNA derived from petals of Nemophila> After reverse transcription reaction of 30 ⁇ g of Nemophila petal-derived total RNA, a homogenized cDNA library was prepared.
- the prepared library was amplified for each clone by emulsion PCR, and then the nucleotide sequence was determined by genome sequencer FLX (Roche Diagnostics Japan Co., Ltd.).
- the obtained sequence data was translated into an amino acid sequence, and a sequence showing homology with the amino acid sequence of gentian anthocyanin 3′-glycosyltransferase was extracted. These sequences were assembled to obtain candidate genes encoding glycosyltransferases.
- Example 4 Obtaining a full-length cDNA sequence of a candidate gene of a gene encoding a protein having an activity of transferring a sugar to the 4′-position and the 7-position hydroxyl group of flavone]
- 25 types of glycosyltransferase gene sequences were obtained.
- Experiments were conducted to obtain full-length cDNA sequences for 10 genes (NmGT0-9).
- the full-length cDNA sequence was obtained using GeneRacer Kit (Invitrogen) according to the protocol recommended by the manufacturer.
- a region specific to the clone was selected from the cDNA partial sequence obtained in Example 3, a primer for RACE was designed based on the sequence of this region, and 5 ′ and 3 ′ terminal sequences were obtained by RACE PCR. . Based on this sequence, a primer for amplifying a full-length cDNA sequence is designed, and nemophila cDNA is used as a template, using KOD-plus polymerase (TOYOBO) according to the protocol recommended by the manufacturer. PCR reaction was carried out at 50 ⁇ l (held at 94 ° C. for 2 minutes, repeated for 30 cycles of 94 ° C. for 15 seconds, 55 ° C. for 30 seconds, 68 ° C. for 2 minutes, and then held at 4 ° C.).
- TOYOBO KOD-plus polymerase
- Nemophila cDNA was synthesized according to the protocol recommended by the manufacturer using SuperScript II Reverse Transcriptase (Invitrogen), using the total RNA isolated in Example 2 as a template.
- the primers were designed so that restriction enzyme sites were included at both ends of the full-length cDNA so that the NmGT0-9 gene could be inserted into the E. coli expression vector pET15b (Novagen).
- pTOPO-NmGT09 plasmid containing the full length of the NmGT gene (pTOPO-NmGT0-9) is obtained according to the protocol recommended by the manufacturer using Zero Blunt TOPO PCR Cloning kit for sequencing (invitrogen). did.
- NmGT0 to 9 The nucleotide sequence inserted into the plasmid was analyzed, and a full-length cDNA sequence of a gene candidate gene (NmGT0 to 9) encoding a protein having an activity of transferring sugars to the 4′-position and the 7-position of flavone was obtained (NmGT3 : SEQ ID NO: 1, NmGT4: SEQ ID NO: 3).
- Example 5 Experiment for measuring enzyme activity of candidate protein having activity of transferring sugar to hydroxyl groups at positions 4 ′ and 7 of flavone (when using crude enzyme)] ⁇ Preparation of E. coli expression construct>
- pTOPO-NmGT0-9 Each 3 ⁇ g of pTOPO-NmGT0-9 was treated with the corresponding restriction enzyme, and the obtained DNA fragment of about 1.5 kb was recovered.
- 2 ⁇ g of vector pET15b was also treated with a restriction enzyme and ligated with the obtained DNA fragment to prepare an E. coli expression construct (pET-NmGT0-9).
- pET-NmGT0-9 was introduced into E. coli strain BL2 using One Shot BL21 (DE3) (invitrogen) according to the protocol recommended by the manufacturer to obtain transformed E. coli.
- This Escherichia coli was cultured using an Overnight Express Autoinduction System 1 (Novagen) according to the protocol recommended by the manufacturer.
- transformed E. coli was cultured at 37 ° C. until the OD600 value reached 0.5 (about 4 hours).
- This Escherichia coli solution was added as a preculture solution to 50 ml of the culture solution, followed by main culture at 27 ° C. overnight.
- the Escherichia coli solution cultured overnight was centrifuged (3000 rpm, 4 ° C., 15 minutes), and the collected cells were mixed with 5 ml of sonic buffer (composition: TrisHCl (pH 7.0): 2.5 mM, dithiothreitol (DTT). ): 1 mM, amidinophanylmethanesulfonyl fluoride hydrochloride (APMSF): 10 ⁇ M), pulverized E. coli by sonication, and then centrifuged (15000 rpm, 4 ° C., 10 minutes) to collect the supernatant. . The supernatant was used as a crude enzyme solution. For the centrifugation, Avanti HP-26XP (rotor: JA-2) was used (BECKMAN COULTER).
- NmGT3 and NmGT4 were included in the 7,3′GT cluster. Examples 6-10 below describe NmGT3 and NmGT4 (SEQ ID NOs: 1 and 3, respectively).
- Example 6 Experiment for measuring enzyme activity of protein having activity of transferring sugar to hydroxyl groups at positions 4 'and 7 of flavone (when protein with added His-Tag is purified)] ⁇ Expression of glycosyltransferase in E. coli and protein purification>
- the Escherichia coli strain BL2 into which pET-NmGT3 and pET-NmGT4 described in Example 5 were introduced was cultured in accordance with the protocol recommended by the manufacturer using the Overnight Express Automation System 1 (Novagen). In 8 ml of the prepared culture solution, the transformed Escherichia coli was cultured at 37 ° C. until the OD600 value reached 0.5 (about 4 hours).
- This Escherichia coli solution was added as a preculture solution to 200 ml of the culture solution, and main culture was performed overnight at 25 ° C. The overnight E. coli solution was centrifuged (1000 ⁇ g, 4 ° C., 10 minutes), and the collected cells were transferred to 20 ml of buffer solution (composition; NaCl: 0.5 M, TrisHCl (pH 7.9): 20 mM. , Imidazole: 5 mM, amidinophanyl methanesulfonyl fluoride hydrochloride (APMSF): 10 ⁇ M), pulverized E.
- buffer solution composition; NaCl: 0.5 M, TrisHCl (pH 7.9): 20 mM.
- Imidazole 5 mM
- amidinophanyl methanesulfonyl fluoride hydrochloride (APMSF) 10 ⁇ M
- the NmGT3 protein solution and the NmGT4 protein solution have apigenin, apigenin 4 ′ -glucoside, and apigenin 7-glucoside as substrates, and the 4 ′ position of flavone that can biosynthesize apigenin 4 ′, 7-diglucoside. It was proved to be a protein having an activity of transferring a sugar to the 7th position.
- NmGT3 and 4 proteins were not only apigenin and its glycosylated product, but also luteolin and its glycosylated product, flavonol and its distribution. It has also been demonstrated to have activity against saccharified products and to glycosidize them.
- Livingstone daisy-derived glycosyltransferase gene (Dbs5GT; betanidin5GT) is originally intended to transfer glucose to the 5-position hydroxyl group of betanidin, but either in 4′-position or 7-position of flavonoid in in vitro. It has been reported to show the activity of transferring glucose to the hydroxyl group. It was clarified that the glycosyltransferase derived from this living stone daisy greatly differs in reactivity with the NmGT3, 4 protein of the present invention from flavonoid compounds and betanidin (see FIG. 13).
- NmGT3 and NmGT4 were 31% and homologous were 47% (see FIG. 14).
- ClustalW program of the MacVector application version 9.5, Oxford Molecular Ltd., Oxford, England
- the identity of NmGT3 and NmGT4 at the nucleic acid level was 51%.
- the amino acid sequence having the highest identity with NmGT3 was an enzyme (GenBank accession No. BAD52006) that adds a sugar to the 2′-position of carnation charcononaringenin.
- the identity of the amino acid sequence of the enzyme that adds a sugar to the 2 ′ position of NmGT3 and carnation chalcononaringenin was 32% (see FIG. 15).
- the identity of the nucleic acid level of the enzyme that adds a sugar to the 2 ′ position of NmGT3 and carnation chalcononaringenin was 47%.
- the amino acid sequence having the highest identity with NmGT4 was an enzyme (described in Non-Patent Document 9) that adds a sugar to the 7th position of the flavonoid of Scutellaria.
- the identity of the amino acid sequence of the enzyme that adds a sugar to the 7th position of NmGT4 and the flavonoid of Saganumae was 52% (see FIG. 16).
- the identity of the nucleic acid level of the enzyme that adds sugar to the 7th position of NmGT4 and 7 of the flavonoids of Saganum was 60%.
- Example 7 Expression in Torenia of a gene encoding a protein having an activity of transferring a sugar to both the 4′-position and 7-position hydroxyl groups of flavone
- NmGT3 and NmGT4 gene of the present invention translate a protein having an activity to transfer sugars to both the 4′-position and the 7-position hydroxyl group of flavone in plants
- NmGT3 and NmGT4 Binary vectors pSPB4584 to 4587 were constructed and introduced into Torenia (Summerwave). Details of the introduced construct are shown below (see FIG. 17).
- pSPB4584 is based on a binary vector pBINPLUS for plant introduction (vanEngel et al., Transgenic Research 4, p288), and has an El235S promoter (Mittsuhara et al., () with an enhancer sequence repeated twice upstream of the cauliflower mosaic virus 35S promoter. 1996) Plant Cell Physiol.37, p49), full length cDNA NmGT3 and mas terminator.
- pSPB4585 has pBINPLUS as a basic skeleton, and contains an El235S promoter, a full-length cDNA NmGT4, and a mas terminator.
- pSPB4586 has two expression cassettes (1.
- pSPB4587 is based on pBINPLUS and includes two expression cassettes (1. El235S promoter and full-length cDNA NmGT8 and mas terminator, 2. El235S promoter and full-length cDNA NmGT4 and mas terminator).
- RNA was isolated in the same manner as described in Example 3, and cDNA synthesis was performed in the same manner as described in Example 4.
- the reverse transcription PCR reaction was performed in 30 ⁇ l using ExTaq polymerase (Takara) using cDNA as a template according to the protocol recommended by the manufacturer (holding at 94 ° C. for 2 minutes, holding at 94 ° C. for 1 minute, The cycle of holding at 55 ° C. for 1 minute and holding at 72 ° C. for 2 minutes was repeated 25 cycles and then held at 4 ° C.)
- Primers were designed to specifically amplify each full-length cDNA. As a result, transcription of NmGT3 and NmGT4 in Torenia was confirmed.
- Example 8 Expression in petunia of a gene encoding a protein having an activity of transferring a sugar to both the 4′-position and the 7-position hydroxyl group of flavone
- Binary vectors pSPB5414 and 5427 for expressing NmGT3 were constructed and introduced into Petunia (Saffinia Bouquet Red). Details of the introduced construct are shown below (see FIG. 18).
- pSPB5414 has pBINPLUS as its basic backbone, four expression cassettes (1. El235S promoter and full-length cDNA pansy F3′5′H (described in PCT / JP2004 / 011958, see SEQ ID NO: 5), and heterologous genes in plants. 2.
- HSP terminator Heat shock protein terminator that is extremely effective for expression (Plant Cell Physiol (2010) 51, 328-332), 2. El235S promoter and full-length cDNA torenia flavone synthase (described in PCT / JP2008 / 061600, sequence No. 7) and HSP terminator, 3. El235S promoter and full-length cDNA NmGT8 and HSP terminator, 4. El235S promoter and full-length cDNA NmGT3 and HSP terminator Netter) is included.
- pSPB5427 has pBINPLUS as the basic backbone, three expression cassettes (1. El235S promoter and full-length cDNA Torenia flavone synthase and HSP terminator, 2. El235S promoter and full-length cDNA NmGT8 and HSP terminator, 3. El235S promoter and full-length cDNA NmGT3 And HSP terminator).
- ⁇ Tissue-specific expression analysis> A shoot is formed in a selective medium containing kanamycin, an individual with rooting is acclimated, and the gene expression analysis is performed in the same manner as described in Example 7 using the leaves of each transformant. It was. As a result, transcription of NmGT3 and NmGT4 in petunia was confirmed.
- Example 9 Expression in carnation of a gene encoding a protein having an activity to transfer sugars to both the 4′-position and 7-position hydroxyl groups of flavone
- a binary vector pSPB5433 for expressing NmGT3 was constructed and introduced into carnation (Cream Cinderella). Details of the introduced construct are shown below (see FIG. 19).
- Snapdragon chalcone synthase promoter described in PCT / AU94 / 00265)
- Example 10 Expression in a rose of a gene encoding a protein having an activity of transferring sugar to both the 4′-position and the 7-position hydroxyl group of flavone
- Binary vectors pSPB4581, 4582, 5437, and 5440 for expressing NmGT3 were constructed and introduced into roses (Knobless, Ritapahumera). Details of the introduced construct are shown below (see FIG. 20).
- pSPB4581 has pBINPLUS as the basic backbone, four expression cassettes (1.
- Sisoanthocyanin 3-acyl transferase promoter (described in PCT / JP2010 / 053909), full-length cDNA pansy F3′5′H and mas terminator; El235S promoter, full-length cDNA torenia flavone synthase and mas terminator, 3. El235S promoter, full-length cDNA NmGT8 and mas terminator, 4. El235S promoter, full-length cDNA NmGT3 and mas terminator).
- pSPB4582 is based on pBINPLUS and is composed of four expression cassettes (1.
- Pansy F3′5′H promoter (PCT / JP2010 / 053909), full-length cDNA pansy F3′5′H and mas terminator, 2. El235S promoter and complete Long cDNA torenia flavone synthase, mas terminator, 3. El235S promoter, full length cDNA NmGT8, mas terminator, 4. El235S promoter, full length cDNA NmGT3, mas terminator).
- pSPB5437 has pBINPLUS as a basic skeleton, five expression cassettes (1. El235S promoter, full-length cDNA pansy F3′5′H and HSP terminator, 2.
- sythoanthocyanin 3-acyltransferase enzyme chromosomal gene (PCT / JP2010 / 053909). 3) El235S promoter, full-length cDNA torenia flavone synthase and HSP terminator, 4. El235S promoter and full-length cDNA NmGT8 and HSP terminator, 5. El235S promoter and full-length cDNA NmGT3 and HSP terminator) include.
- pSPB5440 is based on pBINPLUS, and is composed of five expression cassettes (1. El235S promoter and full-length cDNA pansy F3′5′H and HSP terminator, 2.
- El235S promoter and cDNA lavender anthocyanin 3-acyltransferase (PCT / JP / 1996/000348, see SEQ ID NO: 10), HSP terminator, 3. El235S promoter, full-length cDNA torenia flavone synthase, HSP terminator, 4. El235S promoter, full-length cDNA NmGT8, HSP terminator, 5. El235S promoter Full length cDNA NmGT3 and HSP terminator).
- Example 11 Acquisition of a candidate gene for a gene encoding a protein having an activity of transferring a sugar to both the 4′-position and the 7-position hydroxyl groups of a flavone derived from Salvia uruginosa
- Salvia uruginosa petals contain apigenin 4 ′, 7-diglucoside (see FIG. 6) as the major flavone.
- Salvia uruginosa is expected to have a gene encoding a protein having an activity of transferring sugars to both the 4′-position and 7-position hydroxyl groups of flavone.
- Example 12 Experiment for measuring enzyme activity of a protein candidate having an activity of transferring a sugar to both the 4′-position and the 7-position hydroxyl group of a flavone derived from Salvia uruginosa ((A protein added with His-Tag was purified Case))]
- ⁇ Preparation of E. coli expression construct> In the same manner as described in Example 5, an E. coli expression construct (pET-SuGT2, 5, 10) was prepared.
- the detector used Shimadzu PDA SPD-M10AVP to detect flavones at 330 nm.
- Shim-Pack ODS 150 mm * 4.6 mm (Shimadzu Corporation) was used.
- liquid A (0.1% TFA aqueous solution
- liquid B 90% methanol aqueous solution containing 0.1% TFA
- the flow rate was 0.6 ml / min.
- the SuGT5 protein solution has the activity of transferring sugars to the 4 ′ and 7 positions of flavone that can biosynthesize apigenin 4 ′, 7-diglucoside using apigenin and apigenin 7-glucoside as substrates.
- SuGT5 is active not only for apigenin and its glycosylated products, but also for luteolin and its glycosylated products, flavonol and its glycosylated products, as well as the aforementioned NmGT3 and 4 proteins. Became clear. On the other hand, the reactivity to the flavonoid compound and betanidin was significantly different from the glycosyltransferase derived from Living Stone Daisy (see FIG. 13).
- the amino acid sequences of SuGT5 and NmGT3 were 38% identical and 47% homologous (see FIG. 23).
- the ClustalW program of the MacVector application version 9.5, Oxford Molecular Ltd., Oxford, England
- the nucleic acid level identity between SuGT5 and NmGT3 was 47%.
- the amino acid sequences of SuGT5 and NmGT4 (SEQ ID NOs: 4 and 6, respectively) were 51% identical and 66% homologous (see FIG. 24).
- the nucleic acid level identity between SuGT5 and NmGT4 was 58%.
- a polynucleotide encoding a protein having an activity of transferring a sugar to both the 4'-position and 7-position hydroxyl groups of flavone was identified for the first time.
- the polynucleotide of the present invention in an appropriate host cell, it is possible to produce a protein having an activity of specifically transferring sugar to both the 4'-position and 7-position hydroxyl groups of flavone.
- a protein having an activity to transfer sugars to both the 4′-position and the 7-position hydroxyl group of flavone is used for modification of flower color by expressing constitutively or tissue-specifically in a plant. Can do.
- the present invention also provides a method for producing a flavone in which sugars are added to the hydroxyl groups at both the 4'-position and the 7-position, and foods, pharmaceuticals, cosmetics and the like obtained by the production method.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
しかしながら、その機能が同定されていない糖転移酵素も未だ多数残っていると考えられている。例えば、フラボノイドの4’位に糖を転移する活性を有するタンパク質をコードする遺伝子や、フラボノイドのA環とB環の2箇所の水酸基に逐次的に糖を転移する活性を有するタンパク質をコードする遺伝子は未だ同定されていない。リビングストンデージー由来の糖転移酵素遺伝子を大腸菌で発現させたタンパク質が、in vitro においてフラボノイドの4’位又は7位のいずれか一方の水酸基にグルコースを転移する活性を示すことが報告されているが、この糖転移酵素の植物体における本来の活性は、ベタニジンの5位の水酸基にグルコースを転移するものである(以下、非特許文献11参照)。
かかる状況の下、本発明が解決しようとする課題は、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチドとその使用を提供することである。
すなわち、本発明は以下の通りのものである。
(a)配列番号1又は3又は12の塩基配列からなるポリヌクレオチド;
(b)配列番号1又は3又は12の塩基配列と相補的な塩基配列からなるポリヌクレオチドとストリジェント条件下でハイブリダイズするポリヌクレオチドであって、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチド;
(c)配列番号2又は4又は13のアミノ酸配列からなるタンパク質をコードするポリヌクレオチド;
(d)配列番号2又は4又は13のアミノ酸配列において、1又は数個のアミノ酸が欠失、置換、挿入、及び/又は付加されたアミノ酸配列からなり、かつ、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチド;及び
(e)配列番号2又は4又は13のアミノ酸配列に対して90%以上の同一性を有するアミノ酸配列を有し、かつ、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチド;
からなる群から選ばれるポリヌクレオチド。
前記[10]に記載の非ヒト宿主を培養し又は生育させ、そして
該非ヒト宿主からフラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質を採取する、
を含む、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質の製造方法。
前記[10]に記載の非ヒト宿主を培養し又は生育させ、そして
該非ヒト宿主から、4’位と7位の両方の水酸基に糖が付加されたフラボンを採取する、
を含む、4’位と7位の両方の水酸基に糖が付加されたフラボンの製造方法。
(a)配列番号1又は3又は12の塩基配列からなるポリヌクレオチド;
(b)配列番号1又は3又は12の塩基配列と相補的な塩基配列からなるポリヌクレオチドとストリジェント条件下でハイブリダイズするポリヌクレオチドであって、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチド;
(c)配列番号2又は4又は13のアミノ酸配列からなるタンパク質をコードするポリヌクレオチド;
(d)配列番号2又は4又は13のアミノ酸配列において、1又は数個のアミノ酸が欠失、置換、挿入、及び/又は付加されたアミノ酸配列からなり、かつ、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチド;及び
(e)配列番号2又は4又は13のアミノ酸配列に対して90%以上の同一性を有するアミノ酸配列を有し、かつ、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチド;
からなる群から選ばれるポリヌクレオチドに関する。
本明細書中、用語「ストリジェント条件」とは、ポリヌクレオチド又はオリゴヌクレオチドと、ゲノムDNAとの選択的かつ検出可能な特異的結合を可能とする条件である。ストリンジェント条件は、塩濃度、有機溶媒(例えば、ホルムアミド)、温度、及びその他公知の条件の適当な組み合わせによって定義される。すなわち、塩濃度を減じるか、有機溶媒濃度を増加させるか、又はハイブリダイゼーション温度を上昇させるかによってストリンジェンシー(stringency)は増加する。さらに、ハイブリダイゼーション後の洗浄の条件もストリンジェンシーに影響する。この洗浄条件もまた、塩濃度と温度によって定義され、塩濃度の減少と温度の上昇によって洗浄のストリンジェンシーは増加する。したがって、用語「ストリンジェント条件」とは、各塩基配列間の「同一性」又は「相同性」の程度が、例えば、全体の平均で約80%以上、好ましくは約90%以上、より好ましくは約95%以上、さらに好ましくは97%以上、最も好ましくは98%以上であるような、高い相同性を有する塩基配列間のみで、特異的にハイブリダイズするような条件を意味する。「ストリンジェント条件」としては、例えば、温度60℃~68℃において、ナトリウム濃度150~900mM、好ましくは600~900mM、pH 6~8であるような条件を挙げることができ、具体例としては、5 x SSC (750 mM NaCl、75 mM クエン酸三ナトリウム)、1% SDS、5 x デンハルト溶液50% ホルムアルデヒド、及び42℃の条件でハイブリダイゼーションを行い、0.1 x SSC (15 mM NaCl、1.5 mM クエン酸三ナトリウム)、0.1% SDS、及び55℃の条件で洗浄を行うものを挙げることができる。
また、本発明に係るDNAは、当業者に公知の方法、例えば、ホスホアミダイド法等により化学的に合成する方法、植物の核酸試料を鋳型とし、目的とする遺伝子のヌクレオチド配列に基づいて設計したプライマーを用いる核酸増幅法などによって得ることができる。
あるいは短縮されたアミノ酸配列からなる酵素をコードするDNAを得るには、例えば、目的とするアミノ酸配列より長いアミノ酸配列、例えば、全長アミノ酸配列をコードするDNAを所望の制限酵素により切断し、その結果得られたDNA断片が目的とするアミノ酸配列の全体をコードしていない場合は、不足部分の配列からなるDNA断片を合成し、連結すればよい。
宿主としては、原核生物又は真核生物を用いることがきる。原核生物としては細菌、例えば、エシェリヒア(Escherichia)属に属する細菌、例えば、大腸菌(Escherichia coli)、バシルス(Bacillus)属微生物、例えば、バシルス・スブシルス(Bacillus subtilis)など常用の宿主を用いることができる。真核生物としては、下等真核生物、例えば、真核微生物、例えば、真菌である酵母又は糸状菌が使用できる。
発現ベクターの作製は、制限酵素、リガーゼなどを用いて常法に従って行うことができる。また、発現ベクターによる宿主の形質転換も常法に従って行うことができる。
本明細書では、ネモフィラ又はサルビア由来のフラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードする遺伝子について述べているが、本発明に係るポリヌクレオチドは、ネモフィラ又はサルビア由来の遺伝子に限定されるものではなく、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードする遺伝子の起源としては植物でも動物でも微生物であってもよく、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有している限り、起源を問わず、植物における花色の変更に利用可能である。
[実施例1:ネモフィラ花弁におけるフラボンの4’位と7位の水酸基に糖を転移する活性の検出]
ネモフィラ(Nemophila menziesii)の花弁を、以下のように定義した発達段階に分けて採取し、液体窒素で凍らせ、-80℃冷凍庫で保存した:
ステージ1:色が付いていない堅く閉じたつぼみ(約2-5mm);
ステージ2:有色の堅く閉じたつぼみ(約2-5mm);
ステージ3:有色の閉じたつぼみ、がく片がちょうど開こうとしているつぼみ(約5-10mm);
ステージ4:花弁が開こうとしているつぼみ(約10-15mm)
ステージ5:完全にひらいた花
アントシアニンが生合成される前の花弁のステージ1と2で、フラボン糖転移酵素活性が検出されることが期待される。そこで、ステージ1と2の花弁を用いて、花弁抽出液を調製した。500mgの花弁サンプル(-80℃で保存していたステージ1と2のサンプル250mgずつ)を液体窒素で冷やしながら乳鉢ですりつぶし、1.5mlの抽出バッファー(組成;リン酸カリウム緩衝液(pH7.5):100mM、ジチオスレイトール(DTT):1mM、ポリビニルピロリドン40:50mg/ml、スクロース:100mg/ml)に溶かした。得られたタンパク質溶液を遠心分離(10000rpm、4℃、10分間)し、回収した上清に30%の飽和濃度となるように硫酸アンモニウムを加えた。4℃で1時間撹拌した後、遠心分離(10000rpm、4℃、10分間)して上清を回収した。得られた上清に硫酸アンモニウムを飽和濃度70%となるように添加し、4℃で1時間撹拌した後、遠心分離(10000rpm、4℃、10分間)して沈澱を得た。この沈澱を500μlの溶出バッファー(組成;TrisHCl(pH7.5):2.5mM、DTT:1mM、アミジノファニルメタンスルフォニルフルオライド塩酸(APMSF):10μM)に溶かし、NAP-5Colums Sephadex G-25 DNA Grade(GE Healthcare社)を用いてカラム精製を行って、硫酸アンモニウムを取り除いた。この液を「花弁抽出液」とした。遠心分離には、Avanti HP-26XP(ローター:JA-2)を使用した(BECKMAN COULTER社)。
40μlの花弁抽出液、20μlの5mM UDP-グルコース、20μlの1M TrisHCl(pH7.5)、1μlの500ng/μl アピゲニンを混合し、水で200μlになるように氷上で調整した反応液を、30℃で1時間保持した。その後、200μlの停止バッファー(0.1%TFAを含む90%アセトニトリル水溶液)を加えて反応を停止させ、反応液を高速液体クロマトグラフィー(Prominence(島津製作所))にて分析した。検出器は島津PDA SPD-M10AVPを用い330nmでフラボンを検出した。カラムはShim-Pack ODS 150mm*4.6mm(島津製作所)を用いた。溶出には、A液(0.1%TFA水溶液)とB液(0.1%TFAを含む90%アセトニトリル水溶液)を用いた。両者の8:2の混合液から3:7の混合液までの10分間の直線濃度勾配とそれに続く5分間3:7の混合液による溶出を行なった。流速は0.6ml/分とした。コントロールとして、花弁抽出液を100℃20分で熱処理した花弁抽出液を用いて同じ条件下で酵素反応させた反応液を用いた。
その結果、アピゲニン4’,7-ジグルコシド精製品と同じ保持時間・吸収極大を示すフラボンが生合成された(図7参照)。UDP-グルコースを加えずに酵素反応したときには、何も生合成されなかった。これらの結果より、ネモフィラ花弁には、UDP-グルコースに依存したフラボンの4’位と7位の水酸基に糖を転移する活性を有するタンパク質が存在することが分かった。
フラボン4’,7-ジグルコシドの生合成経路を明らかにするためにアピゲニン4’ -グルコシドの保持時間・吸収極大を決定することにした。
実施例1におけるアピゲニン4’,7-ジグルコシドが生合成される過程で、アピゲニン4’ -グルコシドとアピゲニン7-グルコシドが中間生成物として生合成されるはずである(図8参照)。実施例1の解析結果において、標品があるアピゲニン7-グルコシド、アピゲニン4’,7-ジグルコシド以外のピークが現れることを期待した。
その結果、アピゲニン7-グルコシドと近い保持時間を示すフラボンが生合成されており、これがアピゲニン4’ -グルコシドであると判断された(図7参照)。アピゲニン4’ -グルコシドの保持時間・吸収極大を決定することができた。
<totalRNAの単離>
Plant RNAeasy Kit(QIAGEN社)を用い、製造者に推奨されているプロトコールに従い、ネモフィラのステージ1と2の花弁からtotalRNAを単離した。
<ネモフィラの花弁由来のcDNAの発現解析>
30μgのネモフィラの花弁由来totalRNAの逆転写反応を行った後、均一化cDNAライブラリーを作製した。作製したライブラリーをエマルジョンPCRによって、クローンごと増幅した後、ゲノムシークエンサーFLX(Roche Diagnostics Japan株式会社)により塩基配列の決定を行った。また、得られた配列データをアミノ酸配列に翻訳し、リンドウのアントシアニン3’-糖転移酵素のアミノ酸配列と相同性を示す配列を抽出した。これらの配列をアセンブルし、糖転移酵素をコードする候補遺伝子を得た。
実施例3では糖転移酵素遺伝子の配列が25種得られた。その内10個の遺伝子(NmGT0~9)について完全長cDNA配列を取得するための実験を行った。
完全長cDNA配列の取得は、GeneRacer Kit(invitrogen社)を用いて、製造者に推奨されているプロトコールに従って行った。実施例3で得られたcDNA部分配列の中からそのクローンに特異的な領域を選び、この領域の配列に基づいてRACE用プライマーを設計し、RACE PCRによって5’,3’末端配列を得た。この配列をもとに、完全長cDNA配列を増幅するためのプライマーを設計し、ネモフィラcDNAを鋳型にして、KOD-plus polymerase(TOYOBO社) を用いて、製造者に推奨されているプロトコールに従い、50μlでPCR反応を行った(94℃で2分間保持し、94℃15秒間、55℃30秒間、68℃で2分間のサイクルを30サイクル繰り返した後、4℃で保持した)。ネモフィラのcDNAは、SuperScriptII Reverse Transcriptase(invitrogen社)を用いて、実施例2で単離したtotal RNAを鋳型にして、製造者に推奨されているプロトコールに従って合成した。プライマーは、大腸菌発現ベクターpET15b(Novagen社)にNmGT0~9遺伝子を挿入できるよう、完全長cDNAの両端に制限酵素サイトが含まれるように設計した。このPCR生成物を用いて、Zero Blunt TOPO PCR Cloning kit for sequencing(invitrogen)を用いて、製造者に推奨されているプロトコールに従って、NmGT遺伝子の完全長を含むプラスミド(pTOPO-NmGT0~9)を取得した。プラスミドに挿入された塩基配列を解析し、フラボンの4’位と7位に糖を転移する活性を有するタンパク質をコードする遺伝子の候補遺伝子(NmGT0~9)の完全長cDNA配列を取得した(NmGT3:配列番号1、NmGT4:配列番号3)。
<大腸菌発現コンストラクトの作製>
それぞれ3μgのpTOPO-NmGT0~9を該当する制限酵素で処理し、得られた約1.5kbのDNA断片を回収した。2μgのベクターpET15bも制限酵素で処理し、得られたDNA断片とライゲーションさせて、大腸菌発現コンストラクト(pET-NmGT0~9)を作製した。
pET-NmGT0~9を、One Shot BL21(DE3)(invitorgen)を用いて、製造者に推奨されているプロトコールに従い、大腸菌株BL2へ導入し、形質転換大腸菌を取得した。この大腸菌をOvernight Express Autoinduction System1(Novagen社)を用いて、製造者に推奨されているプロトコールに従い、培養した。調製した培養液2mlで、形質転換大腸菌をOD600値が0.5になるまで37℃で培養した(約4時間)。この大腸菌液を前培養液として、50mlの培養液に加え、27℃で一晩本培養した。
一晩本培養した大腸菌液を遠心分離(3000rpm、4℃、15分間)し、集菌した菌体を5mlのソニックバッファー(組成;TrisHCl(pH7.0):2.5mM、ジチオスレイトール(DTT):1mM、アミジノファニルメタンスルフォニルフルオライド塩酸(APMSF):10μM)に懸濁し、超音波処理により大腸菌を粉砕した後、遠心分離(15000rpm、4℃、10分間)して、上清を回収した。その上清を粗酵素液とした。遠心分離には、Avanti HP-26XP(ローター:JA-2)を使用した(BECKMAN COULTER社)。
80μlの粗酵素液、20μlの5mM UDP-グルコース、20μlの1M TrisHCl(pH7.5)、1μlの500ng/μl のアピゲニンを混合し、水で200μlになるように氷上で調整した反応液を30℃で30分間保持した。その後、200μlの停止バッファー(0.1%TFAを含む90%アセトニトリル水溶液)を加えて反応を停止させ、反応液を高速液体クロマトグラフィー(Prominence(島津製作所))にて分析した。検出器は島津PDA SPD-M10AVPを用い330nmでフラボンを検出した。カラムはShim-Pack ODS 150mm*4.6mm(島津製作所)を用いた。溶出には、A液(0.1%TFA水溶液)とB液(0.1%TFAを含む90%アセトニトリル水溶液)を用いた。両者の8:2の混合液から3:7の混合液までの10分間の直線濃度勾配とそれに続く5分間3:7の混合液による溶出を行なった。流速は0.6ml/分とした。コントロールとして、インサートを挿入しないpETベクターを導入した大腸菌の粗酵素液を用いて同じ条件化で酵素反応させた反応液を用いた。
その結果、NmGT3、NmGT4について、基質以外のピークがみられた。NmGT3、NmGT4は、7,3’GTクラスターに含まれていた。
以下、実施例6~10は、NmGT3とNmGT4(それぞれ、配列番号1と3)について記載する。
<糖転移酵素の大腸菌での発現とタンパク質精製>
実施例5で記載したpET-NmGT3、pET-NmGT4を導入した大腸菌株BL2をOvernight Express Autoinduction System1(Novagen社)を用いて、製造者に推奨されているプロトコールに従い、培養した。調製した培養液8mlで、形質転換大腸菌をOD600値が0.5になるまで37℃で培養した(約4時間)。この大腸菌液を前培養液として、200mlの培養液に加え、25℃で一晩本培養した。
一晩本培養した大腸菌液を遠心分離(1000×g、4℃、10分間)し、集菌した菌体を20mlの緩衝液(組成;NaCl:0.5M、TrisHCl(pH7.9):20mM、イミダゾール:5mM、アミジノファニルメタンスルフォニルフルオライド塩酸(APMSF):10μM)に懸濁し、超音波処理により大腸菌を粉砕した後、遠心分離(1400×g、4℃、20分)して、上清を回収した。その上清を0.45μmフィルターに通し、Profinia(Bio-Rad)を用いて、製造者に推奨されているプロトコールに従って、His-Tag精製した。得られた精製タンパク質溶液を、centrifugal Filters(Ultracel-10K)(Amicon Ultra社)を用いて、遠心分離(7500×g、4℃、15分間)し、その濃縮されたタンパク質溶液を「NmGT3タンパク質溶液」、「NmGT4タンパク質溶液」とした。遠心分離には、Avanti HP-26XP(ローター:JA-2)を使用した(BECKMAN COULTER社)。
20μlのタンパク質溶液、20μlの5mM UDP-グルコース、20μlの1MTrisHCl(pH7.5)、1μlの500ng/μl アピゲニンを混合し、水で200μlになるように氷上で調整した反応液を30℃で20分間保持した。その後、200μlの停止バッファー(0.1%TFAを含む90%アセトニトリル水溶液)を加えて反応を停止させ、反応液を高速液体クロマトグラフィー(Prominence(島津製作所))にて分析した。検出器は島津PDA SPD-M10AVPを用い330nmでフラボンを検出した。カラムはShim-Pack ODS 150mm*4.6mm(島津製作所)を用いた。溶出には、A液(0.1%TFA水溶液)とB液(0.1%TFAを含む90%メタノール水溶液)を用いた。両者の8:2の混合液から3:7の混合液までの10分間の直線濃度勾配とそれに続く6分間3:7の混合液による溶出を行なった。流速は0.6ml/分とした。
既に同定されている糖転移酵素の中で、NmGT3と最も同一性が高いアミノ酸配列は、カーネーションのカルコノナリンゲニンの2’位に糖を付加する酵素(GenBank accession No.BAD52006)であった。NmGT3とカーネーションのカルコノナリンゲニンの2’位に糖を付加する酵素のアミノ酸配列の同一性は32%であった(図15参照)。尚、NmGT3とカーネーションのカルコノナリンゲニンの2’位に糖を付加する酵素の核酸レベルの同一性は47%であった。
既に同定されている糖転移酵素の中で、NmGT4と最も同一性が高いアミノ酸配列は、コガネバナのフラボノイドの7位に糖を付加する酵素(非特許文献9に記載)であった。NmGT4とコガネバナのフラボノイドの7位に糖を付加する酵素のアミノ酸配列の同一性は52%であった(図16参照)。尚、NmGT4とコガネバナのフラボノイドの7位に糖を付加する酵素の核酸レベルの同一性は60%であった。
本発明のNmGT3遺伝子とNmGT4遺伝子が、植物内でフラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質を翻訳するかどうかを確かめるため、NmGT3、NmGT4を発現させるためのバイナリーベクターpSPB4584~4587を構築し、トレニア(サマーウェーブ)へ導入した。導入したコンストラクトの詳細を以下に示す(図17参照)。
<コンストラクトの作製>
pSPB4584は、植物導入用バイナリーベクターpBINPLUS(vanEngel et al.,Transgenic Reserch 4,p288)を基本骨格とし、カリフラワーモザイクウイルス35Sプロモーター上流にエンハンサー配列を2回繰り返してもつEl235Sプロモーター(Mitsuhara et al.,(1996)Plant Cell Physiol.37,p49)と完全長cDNANmGT3とmasターミネーターが含まれている。
pSPB4585は、pBINPLUSを基本骨格とし、El235Sプロモーターと完全長cDNANmGT4とmasターミネーターを含んでいる。
pSPB4586は、pBINPLUSを基本骨格として、2つの発現カセット(1.El235Sプロモーターと完全長cDNANmGT8とmasターミネーター、2.El235Sプロモーターと完全長cDNANmGT3とmasターミネーター)が含まれている。
pSPB4587は、pBINPLUSを基本骨格とし、2つの発現カセット(1.El235Sプロモーターと完全長cDNANmGT8とmasターミネーター、2.El235Sプロモーターと完全長cDNANmGT4とmasターミネーター)が含まれている。
カナマイシンを含む選択培地でシュートを形成し、発根が見られた個体を馴化し、それぞれの形質転換体のガク割れしていないつぼみの花弁を用いて、遺伝子発現解析を行った。totalRNA単離は実施例3に記載した方法と同様にして、cDNA合成は実施例4に記載した方法と同様にして行った。逆転写PCR反応は、cDNAを鋳型として、ExTaq polymarase(Takara社)を用いて、製造者に推奨されているプロトコールに従い、30μlで行った(94℃で2分間保持し、94℃で1分、55℃で1分、72℃で2分間保持のサイクルを25サイクル繰り返した後、4℃で保持した)。それぞれの完全長cDNAが特異的に増幅するようなプライマーを設計した。その結果、トレニアにおけるNmGT3とNmGT4の転写が確認された。
NmGT3を発現させるためのバイナリーベクターpSPB5414、5427を構築し、ペチュニア(サフィニアブーケレッド)へ導入した。導入したコンストラクトの詳細を以下に示す(図18参照)。
<コンストラクトの作製>
pSPB5414は、pBINPLUSを基本骨格とし、4つの発現カセット(1.El235Sプロモーターと完全長cDNAパンジーF3’5’H(PCT/JP2004/011958に記載、配列番号5参照)と、異種遺伝子の植物での発現に極めて有効である熱ショックタンパク質ターミネーター(HSPターミネーター)(Plant Cell Physiol(2010)51,328-332)、2.El235Sプロモーターと完全長cDNAトレニアフラボン合成酵素(PCT/JP2008/061600に記載、配列番号7参照)とHSPターミネーター、3.El235Sプロモーターと完全長cDNANmGT8とHSPターミネーター、4.El235Sプロモーターと完全長cDNANmGT3とHSPターミネーター)が含まれている。
pSPB5427は、pBINPLUSを基本骨格とし、3つの発現カセット(1.El235Sプロモーターと完全長cDNAトレニアフラボン合成酵素とHSPターミネーター、2.El235Sプロモーターと完全長cDNANmGT8とHSPターミネーター、3.El235Sプロモーターと完全長cDNANmGT3とHSPターミネーター)が含まれている。
カナマイシンを含む選択培地でシュートを形成し、発根が見られた個体を馴化し、それぞれの形質転換体の葉を用いて、実施例7に記載した方法と同様にして、遺伝子発現解析を行った。その結果、ペチュニアにおけるNmGT3とNmGT4の転写が確認された。
NmGT3を発現させるためのバイナリーベクターpSPB5433を構築し、カーネーション(クリームシンデレラ)へ導入した。導入したコンストラクトの詳細を以下に示す(図19参照)。
pSPB5433は、植物導入用バイナリーベクターpWTT2132(DNA Plant Technologies, USA=DNAP)を基本骨格とし、4つの発現カセット(1.キンギョソウカルコン合成酵素プロモーター(PCT/AU94/00265に記載)と完全長cDNAパンジーF3’5’HとHSPターミネーター、2.キンギョソウカルコン合成酵素プロモーターと完全長cDNAトレニアフラボン合成酵素とHSPターミネーター、3.カーネーションアントシアニン合成酵素プロモーター(PCT/AU/2009/001659に記載)と完全長cDNANmGT8とHSPターミネーター、4.カーネーションアントシアニン合成酵素プロモーターと完全長cDNANmGT3とHSPターミネーター)が含まれている。
NmGT3を発現させるためのバイナリーベクターpSPB4581、4582、5437、5440を構築し、バラ(ノブレス、リタパヒューメラ)へ導入した。導入したコンストラクトの詳細を以下に示す(図20参照)。
pSPB4581は、pBINPLUSを基本骨格とし、4つの発現カセット(1.シソアントシアニン3-アシル基転位酵素プロモーター(PCT/JP2010/053909に記載)と完全長cDNAパンジーF3’5’Hとmasターミネーター、2.El235Sプロモーターと完全長cDNAトレニアフラボン合成酵素とmasターミネーター、3.El235Sプロモーターと完全長cDNANmGT8とmasターミネーター、4.El235Sプロモーターと完全長cDNANmGT3とmasターミネーター)が含まれている。
pSPB4582は、pBINPLUSを基本骨格とし、4つの発現カセット(1.パンジーF3’5’Hプロモーター(PCT/JP2010/053909)と完全長cDNAパンジーF3’5’Hとmasターミネーター、2.El235Sプロモーターと完全長cDNAトレニアフラボン合成酵素とmasターミネーター、3.El235Sプロモーターと完全長cDNANmGT8とmasターミネーター、4.El235Sプロモーターと完全長cDNANmGT3とmasターミネーター)が含まれている。
pSPB5437は、pBINPLUSを基本骨格とし、5つの発現カセット(1.El235Sプロモーターと完全長cDNAパンジーF3’5’HとHSPターミネーター、2.シソアントシアニン3-アシル基転位酵素染色体遺伝子(PCT/JP2010/053909に記載、配列番号9参照)、3.El235Sプロモーターと完全長cDNAトレニアフラボン合成酵素とHSPターミネーター、4.El235Sプロモーターと完全長cDNANmGT8とHSPターミネーター、5.El235Sプロモーターと完全長cDNANmGT3とHSPターミネーター)が含まれている。
pSPB5440は、pBINPLUSを基本骨格とし、5つの発現カセット(1.El235Sプロモーターと完全長cDNAパンジーF3’5’HとHSPターミネーター、2.El235SプロモータープロモーターとcDNAラベンダーアントシアニン3-アシル基転位酵素(PCT/JP/1996/000348に記載、配列番号10参照)とHSPターミネーター、3.El235Sプロモーターと完全長cDNAトレニアフラボン合成酵素とHSPターミネーター、4.El235Sプロモーターと完全長cDNANmGT8とHSPターミネーター、5.El235Sプロモーターと完全長cDNANmGT3とHSPターミネーター)が含まれている。
サルビアウルギノーサの花弁は、アピゲニン4’,7-ジグルコシド(図6参照)を主要のフラボンとして含有する。よって、サルビアウルギノーサはフラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードする遺伝子を有することが期待される。そこで、サルビアウルギノーサのつぼみから花弁を取得し、PCT/JP2003/010500に記載した方法と同様にして、cDNAライブラリーを作製し、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードする遺伝子の候補遺伝子をスクリーニングした。24個の陽性クローンの塩基配列を決定した結果、7,3’GTクラスターに含まれているcDNA配列を3種取得した(SuGT2、5、10)。これらの遺伝子について、実施例4に記載した方法と同様にして、cDNA完全長を含むプラスミド(pTOPO-SuGT2、5、10)を作製した。プラスミドに挿入された塩基配列を解析し、サルビアウルギノーサ由来のフラボンの4’位と7位に糖を転移する活性を有するタンパク質をコードする遺伝子の候補遺伝子(SuGT2、5、10)の完全長cDNA配列を取得した(SuGT5、配列番号12参照)。
<大腸菌発現コンストラクトの作製>
実施例5に記載した方法と同様にして、大腸菌発現コンストラクト(pET-SuGT2、5、10)を作製した。
実施例5に記載した方法と同様にして、「SuGT2タンパク質溶液」、「SuGT5タンパク質溶液」、「SuGT10タンパク質溶液」を調整した。
20μlのタンパク質溶液、20μlの5mM UDP-グルコース、20μlの1MTrisHCl(pH7.5)、1μlの500ng/μgのアピゲニンを混合し、水で200μlになるように氷上で調整した反応液を30℃で90分間保持した。その後、200μlの停止バッファー(0.1%TFAを含む90%アセトニトリル水溶液)を加えて反応を停止させ、反応液を高速液体クロマトグラフィー(Prominence(島津製作所))にて分析した。検出器は島津PDA SPD-M10AVPを用い330nmでフラボンを検出した。カラムはShim-Pack ODS 150mm*4.6mm(島津製作所)を用いた。溶出には、A液(0.1%TFA水溶液)とB液(0.1%TFAを含む90%メタノールル水溶液)を用いた。両者の8:2の混合液から3:7の混合液までの10分間の直線濃度勾配とそれに続く6分間3:7の混合液による溶出を行なった。流速は0.6ml/分とした。
SuGT5とNmGT4のアミノ酸配列(それぞれ、配列番号4と6)の同一性は51%、相同性は66%であった(図24参照)。尚、SuGT5とNmGT4の核酸レベルの同一性は58%であった。
Claims (19)
- 以下の(a)~(e):
(a)配列番号1又は3又は12の塩基配列からなるポリヌクレオチド;
(b)配列番号1又は3又は12の塩基配列と相補的な塩基配列からなるポリヌクレオチドとストリジェント条件下でハイブリダイズするポリヌクレオチドであって、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチド;
(c)配列番号2又は4又は13のアミノ酸配列からなるタンパク質をコードするポリヌクレオチド;
(d)配列番号2又は4又は13のアミノ酸配列において、1又は数個のアミノ酸が欠失、置換、挿入、及び/又は付加されたアミノ酸配列からなり、かつ、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチド;及び
(e)配列番号2又は4又は13のアミノ酸配列に対して90%以上の同一性を有するアミノ酸配列を有し、かつ、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチド;
からなる群から選ばれるポリヌクレオチド。 - (a)配列番号1又は3又は12の塩基配列からなるポリヌクレオチドである、請求項1に記載のポリヌクレオチド。
- (c)配列番号2又は4又は13のアミノ酸配列からなるタンパク質をコードするポリヌクレオチドである、請求項1に記載のポリヌクレオチド。
- (f)配列番号2又は4又は13のアミノ酸配列に対して、95%以上の同一性を有するアミノ酸配列を有し、かつ、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチドである、請求項1に記載のポリヌクレオチド。
- (g)配列番号2又は4又は13のアミノ酸配列に対して、97%以上の同一性を有するアミノ酸配列を有し、かつ、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチドである、請求項4に記載のポリヌクレオチド。
- (h)配列番号2又は4又は13のアミノ酸配列に対して、98%以上の同一性を有するアミノ酸配列を有し、かつ、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質をコードするポリヌクレオチドである、請求項5に記載のポリヌクレオチド。
- DNAである、請求項1~6のいずれか1項に記載のポリヌクレオチド。
- 請求項1~7のいずれか1項に記載のポリヌクレオチドによりコードされたタンパク質。
- 請求項1~7のいずれか1項に記載のポリヌクレオチドを含有するベクター。
- 請求項9に記載のベクターが導入された非ヒト宿主。
- 請求項1~7のいずれか1項に記載のポリヌクレオチドを用いてフラボンの4’位と7位の両方の水酸基に糖を付加する方法。
- 請求項1~7のいずれか1項に記載のポリヌクレオチドが導入され、かつ、該ポリヌクレオチドを含有する、植物若しくはその子孫又はそれらの部分若しくは組織。
- 切花である、請求項12に記載の植物の部分。
- 請求項13に記載の切花を用いた切花加工品。
- 以下の工程:
請求項10に記載の非ヒト宿主を培養し又は生育させ、そして
該非ヒト宿主からフラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質を採取する、
を含む、フラボンの4’位と7位の両方の水酸基に糖を転移する活性を有するタンパク質の製造方法。 - 以下の工程:
請求項10に記載の非ヒト宿主を培養し又は生育させ、そして
該非ヒト宿主から、4’位と7位の両方の水酸基に糖が付加されたフラボンを採取する、
を含む、4’位と7位の両方の水酸基に糖が付加されたフラボンの製造方法。 - 請求項16に記載の製造方法により製造された4’位と7位の両方の水酸基に糖が付加されフラボンを含有する食品。
- 請求項16に記載の製造方法により製造された4’位と7位の両方の水酸基に糖が付加されフラボンを含有する医薬品。
- 請求項16に記載の製造方法により製造された4’位と7位の両方の水酸基に糖が付加されフラボンを含有する化粧品。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12734422.4A EP2664671A4 (en) | 2011-01-14 | 2012-01-11 | New Glycosyltransferase and its use |
US13/979,717 US9365836B2 (en) | 2011-01-14 | 2012-01-11 | Glycosyltransferase gene and use thereof |
JP2012552745A JP5936553B2 (ja) | 2011-01-14 | 2012-01-11 | 新規糖転移酵素遺伝子及びその使用 |
CA2824747A CA2824747A1 (en) | 2011-01-14 | 2012-01-11 | Novel glycosyltransferase gene and use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011-006317 | 2011-01-14 | ||
JP2011006317 | 2011-01-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012096307A1 true WO2012096307A1 (ja) | 2012-07-19 |
Family
ID=46507201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2012/050379 WO2012096307A1 (ja) | 2011-01-14 | 2012-01-11 | 新規糖転移酵素遺伝子及びその使用 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9365836B2 (ja) |
EP (1) | EP2664671A4 (ja) |
JP (1) | JP5936553B2 (ja) |
CA (1) | CA2824747A1 (ja) |
WO (1) | WO2012096307A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013108794A1 (ja) * | 2012-01-17 | 2013-07-25 | サントリーホールディングス株式会社 | 新規糖転移酵素遺伝子及びその使用 |
WO2015167016A1 (ja) * | 2014-05-02 | 2015-11-05 | サントリーホールディングス株式会社 | 新規糖転移酵素遺伝子及びその使用 |
WO2017169699A1 (ja) * | 2016-03-31 | 2017-10-05 | 国立研究開発法人農業・食品産業技術総合研究機構 | 青系花色を有する植物及びその作出方法 |
US10870861B2 (en) | 2015-07-01 | 2020-12-22 | Suntory Holdings Limited | Creation of chrysanthemum with blue flower color |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109312379B (zh) | 2016-04-05 | 2022-04-12 | 科学与工业研究委员会 | 多功能重组核苷酸依赖性糖基转移酶蛋白及其糖基化的方法 |
CN114032220A (zh) * | 2021-12-13 | 2022-02-11 | 河北省农林科学院经济作物研究所 | 与紫苏花青素生物合成相关蛋白及其编码基因与应用 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999005287A1 (fr) | 1997-07-25 | 1999-02-04 | Suntory Limited | Genes codant pour des proteines a activite de transglycolsylation |
WO2001092509A1 (fr) | 2000-06-02 | 2001-12-06 | International Flower Developments Proprietary Limited | Nouveaux genes de glycosyltransferase |
WO2005017147A1 (ja) | 2003-08-13 | 2005-02-24 | International Flower Developments Proprietary Limited | 花色が変更されたバラの製造方法 |
JP2005095005A (ja) | 2003-09-22 | 2005-04-14 | Aomori Prefecture | 新規グルコシル基転移酵素遺伝子 |
JP2005519940A (ja) * | 2002-03-12 | 2005-07-07 | カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ | クミンとその抽出物及び画分の生物学的利用能/生物学的有効性促進活性 |
JP2006149293A (ja) | 2004-11-30 | 2006-06-15 | Aomori Prefecture | 新規アントシアニジングルコシル基転移酵素遺伝子 |
WO2006105598A1 (en) | 2005-04-04 | 2006-10-12 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg | Plant genetic sequences associated with vacuolar ph and uses thereof |
WO2007094521A1 (ja) | 2006-02-17 | 2007-08-23 | International Flower Developments Proprietary Limited | フラボノイド糖転移酵素及びその利用 |
WO2008156211A1 (ja) | 2007-06-20 | 2008-12-24 | International Flower Developments Proprietary Limited | フラボンを含むバラ及びその生産方法 |
WO2009062253A1 (en) | 2007-11-15 | 2009-05-22 | International Flower Developments Pty Ltd | Genetically modified chrysanthemums |
WO2010122849A1 (ja) | 2009-04-24 | 2010-10-28 | 独立行政法人農業・食品産業技術総合研究機構 | デルフィニジンを花弁に含有するキク植物を生産する方法 |
US20110030090A1 (en) * | 1999-05-07 | 2011-02-03 | E. I. Du Pont De Nemours And Company | Disease resistance genes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4368005B2 (ja) * | 1999-01-29 | 2009-11-18 | インターナショナル フラワー ディベロプメンツ プロプライアタリー リミティド | フラボン合成酵素をコードする遺伝子 |
-
2012
- 2012-01-11 WO PCT/JP2012/050379 patent/WO2012096307A1/ja active Application Filing
- 2012-01-11 EP EP12734422.4A patent/EP2664671A4/en not_active Withdrawn
- 2012-01-11 US US13/979,717 patent/US9365836B2/en not_active Expired - Fee Related
- 2012-01-11 CA CA2824747A patent/CA2824747A1/en not_active Abandoned
- 2012-01-11 JP JP2012552745A patent/JP5936553B2/ja not_active Expired - Fee Related
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999005287A1 (fr) | 1997-07-25 | 1999-02-04 | Suntory Limited | Genes codant pour des proteines a activite de transglycolsylation |
US20110030090A1 (en) * | 1999-05-07 | 2011-02-03 | E. I. Du Pont De Nemours And Company | Disease resistance genes |
WO2001092509A1 (fr) | 2000-06-02 | 2001-12-06 | International Flower Developments Proprietary Limited | Nouveaux genes de glycosyltransferase |
JP2005519940A (ja) * | 2002-03-12 | 2005-07-07 | カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ | クミンとその抽出物及び画分の生物学的利用能/生物学的有効性促進活性 |
WO2005017147A1 (ja) | 2003-08-13 | 2005-02-24 | International Flower Developments Proprietary Limited | 花色が変更されたバラの製造方法 |
JP2005095005A (ja) | 2003-09-22 | 2005-04-14 | Aomori Prefecture | 新規グルコシル基転移酵素遺伝子 |
JP2006149293A (ja) | 2004-11-30 | 2006-06-15 | Aomori Prefecture | 新規アントシアニジングルコシル基転移酵素遺伝子 |
WO2006105598A1 (en) | 2005-04-04 | 2006-10-12 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg | Plant genetic sequences associated with vacuolar ph and uses thereof |
WO2007094521A1 (ja) | 2006-02-17 | 2007-08-23 | International Flower Developments Proprietary Limited | フラボノイド糖転移酵素及びその利用 |
WO2008156211A1 (ja) | 2007-06-20 | 2008-12-24 | International Flower Developments Proprietary Limited | フラボンを含むバラ及びその生産方法 |
WO2009062253A1 (en) | 2007-11-15 | 2009-05-22 | International Flower Developments Pty Ltd | Genetically modified chrysanthemums |
WO2010122849A1 (ja) | 2009-04-24 | 2010-10-28 | 独立行政法人農業・食品産業技術総合研究機構 | デルフィニジンを花弁に含有するキク植物を生産する方法 |
Non-Patent Citations (32)
Title |
---|
"Clustal W program of MacVector application", OXFORD MOLECULAR LTD. |
"Molecular Cloning: A Laboratory Manual, 2nd Ed.,", 1989, COLD SPRING HARBOR LABORATORY PRESS |
BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY, vol. 70, no. 6, 2006, pages 1471 - 1477 |
BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY, vol. 74, no. 9, 2010, pages 1760 - 1769 |
BIOTECHNOLOGY, vol. 9, 1992, pages 358 |
FREDERICK M. AUSUBEL ET AL.,: "Current Protocols in Molecular Biology", 1987 |
GRIBSKOV, M. & DEVEREUX, J.: "Sequence Analysis Primer", 1991, M-STOCKTON PRESS |
GRIFIN, A.M. & GRIFIN, H.G.: "Computer Analysis of Sequence Data", 1994, HUMAN PRESS |
HEINJE, G.: "Sequence Analysis in Molecular Biology", 1987, ACADEMIC PRESS |
JOURNAL OF EXPERIMENTAL BOTANY, vol. 59, no. 6, 2008, pages 1241 - 1252 |
LESK, A.M.: "Computational Molecular Biology", 1988, OXFORD UNIVERSITY PRESS |
MATUBA,Y. ET AL.: "A novel glucosylation reaction on anthocyanins catalyzed by acyl- glucose-dependent glucosyltransferase in the petals of carnation and delphinium", PLANT CELL, vol. 22, 2010, pages 3374 - 3389, XP055080765 * |
MITSUHARA ET AL., PLANT CELL PHYSIOL., vol. 37, 1996, pages 49 |
NATURAL PRODUCT REPORTS, vol. 26, 2009, pages 884 - 915 |
NOGUCHI A. ET AL.: "Local differentiation of sugar donor specificity of flavonoid glycosyltransferase in lamiales", PLANT CELL, vol. 21, 2009, pages 1556 - 1572, XP055080762 * |
PLANT CELL PHYSIOL, vol. 51, 2010, pages 328 - 332 |
PLANT CELL PHYSIOLOGY, vol. 37, no. 5, 1996, pages 711 - 716 |
PLANT CELL PHYSIOLOGY, vol. 48, no. 11, 2007, pages 1589 - 1600 |
PLANT CELL, vol. 22, no. 10, 2010, pages 3374 - 89 |
PLANT CELL, vol. 9, 1997, pages 1357 - 1368 |
PLANT MOLECULAR BIOLOGY, vol. 48, 2002, pages 401 - 411 |
PLANTA, vol. 210, 2000, pages 1006 - 1013 |
See also references of EP2664671A4 |
SMITH, D.W.: "Biocomputing: Informatics and Genome Projects", 1993, ACADEMIC PRESS |
SUZGEC-SELCUK S. ET AL.: "Flavonoids of helichrysum chasmolycicum and its antioxidant and antimicrobial activities", SOUTH AFRICAN J. BOTANY, vol. 77, January 2011 (2011-01-01), pages 170 - 174, XP055115923 * |
THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 11, 1999, pages 7405 - 7411 |
THE PLANT JOURNAL, vol. 19, no. 5, 1999, pages 509 - 519 |
TRENDS IN BIOTECHNOLOGY, vol. 10, 1992, pages 132 |
TRENDS IN BIOTECHNOLOGY, vol. 10, 1992, pages 152 |
TRENDS IN BIOTECHNOLOGY, vol. 10, 1992, pages 87 |
VANENGEL ET AL., TRANSGENIC RESEARCH, vol. 4, pages 288 |
VEITCH N.C. ET AL.: "Flavonoid cellobiosides from salvia uligonosa", PHYTOCHEMISTRY, vol. 48, no. 2, 1998, pages 389 - 393, XP004293998 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013108794A1 (ja) * | 2012-01-17 | 2013-07-25 | サントリーホールディングス株式会社 | 新規糖転移酵素遺伝子及びその使用 |
US10059956B2 (en) | 2012-01-17 | 2018-08-28 | Suntory Holdings Limited | Glycosyltransferase gene and use thereof |
WO2015167016A1 (ja) * | 2014-05-02 | 2015-11-05 | サントリーホールディングス株式会社 | 新規糖転移酵素遺伝子及びその使用 |
JPWO2015167016A1 (ja) * | 2014-05-02 | 2017-04-20 | サントリーホールディングス株式会社 | 新規糖転移酵素遺伝子及びその使用 |
EP3138908A4 (en) * | 2014-05-02 | 2017-11-15 | Suntory Holdings Limited | Novel glycosyltransferase gene and use thereof |
US10087427B2 (en) | 2014-05-02 | 2018-10-02 | Suntory Holdings Limited | Glycosyltransferase gene and use thereof |
US10870861B2 (en) | 2015-07-01 | 2020-12-22 | Suntory Holdings Limited | Creation of chrysanthemum with blue flower color |
WO2017169699A1 (ja) * | 2016-03-31 | 2017-10-05 | 国立研究開発法人農業・食品産業技術総合研究機構 | 青系花色を有する植物及びその作出方法 |
JPWO2017169699A1 (ja) * | 2016-03-31 | 2018-10-25 | 国立研究開発法人農業・食品産業技術総合研究機構 | 青系花色を有する植物及びその作出方法 |
CN108777947A (zh) * | 2016-03-31 | 2018-11-09 | 三得利控股株式会社 | 具有蓝色系花色的植物及其制作方法 |
US11299742B2 (en) | 2016-03-31 | 2022-04-12 | Suntory Holdings Limited | Plant having blue flower color and breeding method therefor |
CN108777947B (zh) * | 2016-03-31 | 2022-11-11 | 三得利控股株式会社 | 具有蓝色系花色的植物及其制作方法 |
Also Published As
Publication number | Publication date |
---|---|
US20140033369A1 (en) | 2014-01-30 |
JPWO2012096307A1 (ja) | 2014-06-09 |
CA2824747A1 (en) | 2012-07-19 |
US9365836B2 (en) | 2016-06-14 |
JP5936553B2 (ja) | 2016-06-22 |
EP2664671A4 (en) | 2014-09-10 |
EP2664671A1 (en) | 2013-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2585767C (en) | A method of adding aromatic acyl groups to sugars at both the 3' and 5 positions of anthocyanins | |
JP6147195B2 (ja) | 新規糖転移酵素遺伝子及びその使用 | |
JP5936553B2 (ja) | 新規糖転移酵素遺伝子及びその使用 | |
JP6602291B2 (ja) | 新規糖転移酵素遺伝子及びその使用 | |
JP4691720B2 (ja) | 新規アントシアニジングルコシル基転移酵素遺伝子 | |
JP7146754B2 (ja) | マロニル基転移酵素遺伝子の使用 | |
WO2022107857A1 (ja) | フラボン4'-o-メチル基転移酵素遺伝子及びその使用 | |
WO2024135619A1 (ja) | フラバノン2-水酸化酵素遺伝子及びその使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12734422 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2012552745 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2824747 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13979717 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012734422 Country of ref document: EP |